MD Stock Analysis: Buy, Sell, or Hold?
MD - Pediatrix Medical Group, Inc.
$20.80
0.30 (1.46%)
▲
5d:
+0.97%
30d:
+4.79%
90d:
-4.89%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When MD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: MD shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$26.95
Based on 4.1% avg growth
INTRINSIC VALUE TODAY
$16.74
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MD is currently trading at $20.80, which is considered extended relative to its 30-day fair value range of $19.39 to $20.45. The stock's valuation (Forward PE: 8.8) is in line with its historical norms (9.5). Remarkably, the market is currently pricing in an annual earnings decline of 2.6% over the next few years. This pessimistic expectation contrasts with the company's recent 11.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, MD is in a strong downtrend. The price is approaching resistance at $21.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MD is in a strong downtrend. The price is approaching resistance at $21.42. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: MD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$19.39 -
$20.45
Company Quality Score
59/100
(HOLD)
Options IV Signal
50th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
59.6%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Options fairly priced (IV 50th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($21.33)
Fair Price Analysis
30-Day Fair Range
$19.39 -
$20.45
Current vs Fair Value
EXTENDED
Expected Move (7 Days)
±$1.47
(7.1%)
Support & Resistance Levels
Support Level
$19.33
Resistance Level
$21.42
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.81
Wall Street Target
$21.33
(+4.1%)
Revenue Growth (YoY)
-1.7%
Earnings Growth (YoY)
11.4%
Profit Margin
8.6%
Valuation Discount vs History
-2.6% cheaper
PE vs Historical
8.8 vs 9.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.6%
(market-implied from PE analysis)
1-Year Target
$19.97
(-3%)
2-Year Target
$19.45
(-5%)
3-Year Target
$18.94
(-8%)
3-Yr Target (if PE normalizes)
(PE: 9→10)
$20.42
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 4.1%)
$58.81
(+187%)
Base:
(SPY PE: 8.8, Growth: 4.1%)
$23.14
(+13%)
Bear:
(PE: 7.5, Growth: 4.1%)
$19.67
(-4%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (10x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 10.15 | Current EPS (TTM): $1.94
Bull Case
$25.98
(+26%)
Analyst growth 19.9%, PE expands to 11.2
Base Case
$23.62
(+15%)
Market implied 19.9%, PE stable at 10.2
Bear Case
$13.40
(-35%)
Severe decline -20.0%, PE contracts to 8.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.8 to 9.5
Stabilization Target:
$22.10
(+7.8%)
PE Expansion Potential:
+7.8%
Share & Embed Analysis
Last updated: March 30, 2026 4:29 PM ET
Data refreshes hourly during market hours. Next update: 5:29 PM
Data refreshes hourly during market hours. Next update: 5:29 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Mark S Ordan
SELL
23000 shares
2025-12-15
Michael A Rucker
SELL
10478 shares
2025-11-17
Laura A Linynsky
SELL
10000 shares
2025-11-06
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$140 | 54 HOLD |
